OSCR earnings

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its first quarter 2026 financial results before the market opens on Wednesday, May 6, 2026. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following May 6, 2026 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform and a relentl

Achieves Record Membership of ~3.4 Million and Provides Full-Year 2026 Outlook Including More Than $18 Billion in Revenue Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the fourth quarter and full year ended December 31, 2025. "2025 was a reset year for the individual market, and we took decisive actions to return to profitability in 2026," said Mark Bertolini, CEO of Oscar Health. "Our new suite of affordable products, agentic AI features, and exceptional member experience drove record-high membership – positioning us to achieve significantly improved financial performance in 2026. Oscar's growth demonstrates consumers vote where the

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2025 financial results before the market opens on Tuesday, February 10, 2026. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following February 10, 2026 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack techno

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the third quarter ended September 30, 2025, and reaffirmed its full year 2025 outlook, across all metrics, as provided in its preliminary financial results press release dated July 22, 2025. "The individual market is the only source of affordable health coverage for 22 million people who power our economy," said Mark Bertolini, CEO of Oscar Health. "Our market serves the small business, service, and farming sectors, and can meet the healthcare needs of 100 million more working people. Oscar is shaping the future of individual healthcare with affordable, innovative plans and a superior member

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following November 6, 2025 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform an

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the second quarter ended June 30, 2025, and reaffirmed its updated full year 2025 outlook across all metrics as provided in its preliminary financial results press release dated July 22, 2025. "We believe the individual market has long-term upside and is the future of healthcare," said Mark Bertolini, CEO of Oscar Health. "Oscar is well-positioned to manage through the market reset in 2025. We believe the market will stabilize next year, and expect to return to profitability in 2026. We are building the individual market into a healthcare marketplace for more consumers and businesses, and c

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 and updates to full year 2025 guidance. The Company expects a loss from operations of approximately $230 million and a net loss of approximately $228 million for the second quarter of 2025. The preannouncement is driven by a review of 2025 Marketplace data ("2Q Risk Adjustment Reports") from Wakely, an independent actuarial firm, that analyzes paid claims submissions through April 30, 2025 for most Marketplace insurance carriers. "The individual market is a competitive healthcare marketplace tha

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, announced today its financial results for the first quarter ended March 31, 2025. "Oscar reported strong financial results in the first quarter," said Mark Bertolini, CEO of Oscar Health. "We delivered continued top-line growth and bottom-line performance with significant year-over-year increases in revenue and net income. We continue to expect meaningful margin expansion this year as we deliver superior value to our members and partners." Oscar is reaffirming its full year 2025 outlook across all metrics as provided in its financial results press release dated February 4, 2025. First Qu

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following May 7, 2025 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform and a relentless

Reports Adjusted EBITDA and Net Income Profitability for the First Time in Company History For the year ended December 31, 2024: Total Revenue of $9.2 billion, a 56.5% increase year-over-year Medical Loss Ratio of 81.7%, a 10 bps increase year-over-year SG&A Expense Ratio of 19.1%, a 520 bps improvement year-over-year Net income attributable to Oscar of $25.4 million, or $0.10 of diluted earnings per share, a $296.2 million improvement year-over-year Adjusted EBITDA of $199.2 million, an improvement of $244.5 million year-over-year Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced its financial results

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2024 financial results after the market closes on Tuesday, February 4, 2025. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following February 4, 2025 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technolo

For the quarter ended September 30, 2024: Total Revenue of $2.4 billion, a 68% increase year-over-year Medical Loss Ratio of 84.6%, an 80 bps increase year-over-year SG&A Expense Ratio of 19.0%, a 360 bps improvement year-over-year Net loss attributable to Oscar of $54.6 million, or $(0.22)  of earnings per share, a $10.8 million improvement year-over-year Adjusted EBITDA loss of $11.6 million, an $8.7 million improvement year-over-year Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced its financial results for the third quarter ended September 30, 2024. "Oscar reported positive third quarter results with stro

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its third quarter 2024 financial results before the market opens on Thursday, November 7, 2024. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.888.596.4244 Conference ID: 7768132 Webcast Link The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following November 7, 2024 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform an

For the quarter ended June 30, 2024: Total Revenue of $2.2 billion, a 46% increase YoY Medical Loss Ratio of 79.0%, a 90 bps improvement YoY SG&A Expense Ratio of 19.6%, a 260 bps improvement YoY Net income attributable to Oscar of $56.2 million, or $0.20 of diluted earnings per share, a $71.7 million improvement YoY Adjusted EBITDA of $104.1 million, a $68.6 million improvement YoY Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced its financial results for the second quarter ended June 30, 2024. "Oscar reported strong second quarter results, closing out the best six months in the company's history," sa

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its second quarter 2024 financial results before the market opens on Wednesday, August 7, 2024. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: (888) 596-4244 Conference ID: 776-8132 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following August 7, 2024 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology pl

For the quarter ended March 31, 2024: Total Revenue of $2.1 billion, a 46% increase YoY Medical Loss Ratio of 74.2%, a 210 bps improvement YoY SG&A Expense Ratio of 18.4%, an 870 bps improvement YoY Net Income attributable to Oscar of $177.4 million, or $0.62 of diluted earnings per share, a $217.1 million improvement YoY Adjusted EBITDA of $219.3 million, a $168.2 million improvement YoY Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced its financial results for the first quarter ended March 31, 2024. "Oscar reported strong first quarter results, showing year-over-year improvement across all core metri

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: (888) 596-4244 Conference ID: 776-8132 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following May 7, 2024 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology platform and a relentless

For the year ended December 31, 2023: Direct and Assumed Policy Premiums of $6.6 billion, a 3% decrease YoY Premiums earned of $5.7 billion, a 47% increase YoY Medical Loss Ratio of 81.6%, a 370 bps improvement YoY InsuranceCo Administrative Expense Ratio of 17.9%, a 270 bps improvement YoY InsuranceCo Combined Ratio of 99.5%, a 640 bps improvement YoY Adjusted Administrative Expense Ratio of 21.0%, a 350 bps improvement YoY Net loss of $271 million, an improvement of $339 million YoY Adjusted EBITDA loss of $45 million, an improvement of $417 million YoY Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today a

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2023 financial results after the market closes on Wednesday, February 7, 2024. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (877) 400-4403 Conference ID: 6577079 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following February 7, 2024 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology

For the quarter ended September 30, 2023: Direct and Assumed Policy Premiums of $1.6 billion, a 5% decrease YoY Premiums earned of $1.4 billion, a 46% increase YoY Medical Loss Ratio of 83.8%, a 608 bps improvement YoY Net loss of $65.7 million, an improvement of $127.8 million YoY Adjusted EBITDA loss of $20.3 million, an improvement of $139.5 million YoY InsuranceCo Administrative Expense Ratio of 17.4%, a 326 bps improvement YoY InsuranceCo Combined Ratio of 101.3%, a 934 bps improvement YoY Adjusted Administrative Expense Ratio of 20.3%, a 443 bps improvement YoY Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology comp

For the quarter ended June 30, 2023: Direct and Assumed Policy Premiums of $1.6 billion, a 3% decrease YoY Premiums earned of $1.5 billion, a 48% increase YoY Medical Loss Ratio of 79.9%, a 230 bps improvement YoY Net loss of ($15.4) million, an improvement of $96.7 million YoY Adjusted EBITDA of $35.6 million, an improvement of $111.4 million YoY InsuranceCo Administrative Expense Ratio of 16.7%, a 280 bps improvement YoY InsuranceCo Combined Ratio of 96.7%, a 500 bps improvement YoY Adjusted Administrative Expense Ratio of 19.5%, a 420 bps improvement YoY Health tech company Oscar Health, Inc. (NYSE:OSCR) today announced its financial results for the second q

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, will release its second quarter 2023 financial results after market close on Tuesday, August 8, 2023. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (877) 400-4403 Conference ID: 6577079 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following August 8, 2023. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology platform and a

For the quarter ended March 31, 2023: Direct and Assumed Policy Premiums of $1.7 billion, a 2% increase YoY Premms earned of $1.4 billion, a 50% increase YoY Medical Loss Ratio of 76.3%, a 108 bps improvement YoY Net loss of $39.6 million, an improvement of $37.7 million YoY Adjusted EBITDA of $51.1 million, an improvement of $88.1 million YoY InsuranceCo Administrative Expense Ratio of 18.6%, a 121 bps improvement YoY InsuranceCo Combined Ratio of 94.9%, a 230 bps improvement YoY Adjusted Administrative Expense Ratio of 21.7%, a 206 bps improvement YoY Health tech company Oscar Health, Inc. (NYSE:OSCR) today announced its financial results for the first quarte

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, will release its first quarter 2023 financial results after market close on Tuesday, May 9, 2023. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: ● Live Call: (877) 400-4403 ● Conference ID: 6577079 ● Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following May 9, 2023. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology platform and a re

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built around a full-stack technology platform, today announced the appointment of Mark Bertolini to the role of Chief Executive Officer, effective April 3, 2023. Co-Founder Mario Schlosser, will transition to President of Technology, reporting to Mark. In his new role, Mario will lead product and engineering, with a focus on building Oscar's tech platform for the future and continuing to set the strategy for the +Oscar roadmap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230328005389/en/Mario Schlosser, Mark Bertolini, Joshua Kushner (Photo: Business

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, will release its fourth quarter 2022 and full year 2022 financial results after market close on Thursday, February 9, 2023. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (877) 400-4403 Conference ID: 6577079 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following February 9, 2023. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack techno

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, will release its third quarter 2022 financial results after market close on Tuesday, November 8, 2022. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (877) 400-4403 Conference ID: 6577079 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following November 8, 2022. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology platform and a r

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, will release its second quarter 2022 financial results after market close on Thursday, August 11, 2022. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (888) 550-4423 Conference ID: 5511974 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following August 11, 2022. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology platform and a re

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, will release its first quarter 2022 financial results after market on Tuesday, May 10, 2022. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (833) 979-2864 Conference ID: 4895772 Webcast Link The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following May 10, 2022. About Oscar Health Oscar Health, Inc. is the first health insurance company built around a full stack technology platform and a relentless focus on serving

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, will host a virtual investor day conference on Friday, March 25, 2022. Management will present to investors in a conference call beginning at 9:00 AM ET. Members of Oscar's management team will discuss Oscar's 2021 performance, vision, strategic plans, guidance for expected fiscal 2022 financial performance, long-term growth targets, and the levers available to achieve these targets. The registration page and webcast link are as follows: Registration Page / Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com)

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, will release its 2021 fourth quarter and full year 2021 financial results after market on Thursday, February 10, 2022. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (833) 979-2864 Conference ID: 1469889 Webcast Link The call will be archived and available on Oscar's investor relations website (https://ir.hioscar.com) following February 10, 2022. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technol

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, will release its third quarter results after market on Wednesday, November 10, 2021. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (833) 979-2864 Conference ID: 3838797 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following November 10, 2021. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology platform and a relentless focus on